Cited by 1,304Antioxidant Activity and Oxidative StressNitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record, with a small difference in title or year; 39 of the 39 references it cites were found in a registry or an index.

Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study

Keaney, John F., Larson, Martin G., Vasan, Ramachandran S., Wilson, Peter W.F., Lipinska, Izabella, Corey, Diane, Massaro, Joseph M., Sutherland, Patrice, Vita, Joseph A., Benjamin, Emelia J.·2003·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.0000058402.34138.11

Open this paper in CoChat — free account

Abstract

Objective— To determine the clinical conditions associated with systemic oxidative stress in a community-based cohort. Information regarding cardiovascular risk factors associated with systemic oxidative stress has largely been derived from highly selected samples with advanced stages of vascular disease. Thus, it has been difficult to evaluate the relative contribution of each cardiovascular risk factor to systemic oxidative stress and to determine whether such risk factors act independently and are applicable to the general population. Methods and Results— We examined 2828 subjects from the Framingham Heart Study and measured urinary creatinine–indexed levels of 8-epi-PGF 2α as a marker of systemic oxidative stress. Age- and sex-adjusted multivariable regression models were used to assess clinical correlates of oxidative stress. In age- and sex-adjusted models, increased urinary creatinine–indexed 8-epi-PGF 2α levels were positively associated with female sex, hypertension treatment, smoking, diabetes, blood glucose, body mass index, and a history of cardiovascular disease. In contrast, age and total cholesterol were negatively correlated with urinary creatinine–indexed 8-epi-PGF 2α levels. After adjustment for several covariates, decreasing age and total/HDL cholesterol ratio, sex, smoking, body mass index, blood glucose, and cardiovascular disease remained associated with urinary 8-epi-PGF 2α levels. Conclusions— Smoking, diabetes, and body mass index were highly associated with systemic oxidative stress as determined by creatinine-indexed urinary 8-epi-PGF 2α levels. The effect of body mass index was minimally affected by blood glucose, and diabetes and may suggest an important role of oxidative stress in the deleterious impact of obesity on cardiovascular disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000058402.34138.11

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898
Ascorbate is an outstanding antioxidant in human blood plasma
Frei, B., England, L., & Ames, B. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6377 · Cited by 1,870
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
Morrow, J. D., Frei, B. B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,340
Role of Superoxide in Angiotensin II–Induced but Not Catecholamine-Induced Hypertension
Laursen, J. B., Rajagopalan, S., Galis, Z. S., Tarpey, M. M., Freeman, B. Α., & Harrison, D. G. (1997) · Circulation · doi:10.1161/01.cir.95.3.588 · Cited by 820
In Vivo Formation of 8-Iso-Prostaglandin F2αand Platelet Activation in Diabetes Mellitus: Effects of Improved Metabolic Control and Vitamin E Supplementation
Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742
Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., & Vlassara, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6434 · Cited by 571
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.
Heinecke, J. W., Baker, L., Rosen, H., & Chait, A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112371 · Cited by 517
Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
Rudich, A., Tirosh, A., Potashnik, R., Hemi, R., Kanety, H., & Bashan, N. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1562 · Cited by 483
Factors Associated with Oxidative Stress in Human Populations
Block, G. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf029 · Cited by 476
Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid
Frei, B. B., Forte, T. M., Ames, B. N., & Cross, C. E. (1991) · Biochemical Journal · doi:10.1042/bj2770133 · Cited by 471
Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus
Gopaul, N. K., Änggård, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., & Nourooz-Zadeh, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00649-t · Cited by 390
Greater Oxidative Stress in Healthy Young Men Compared With Premenopausal Women
Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H., & Takeshita, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.104515 · Cited by 357
Correlates of Markers of Oxidative Status in the General Population
Trevisan, M. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.4.348 · Cited by 351
The generation and actions of isoprostanes
Roberts, L. J., & Morrow, J. D. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00162-2 · Cited by 305
Range of serum cholesterol values in the population developing coronary artery disease
Kannel, W. B. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80474-3 · Cited by 289
Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM
Nourooz‐Zadeh, J., Tajaddini-Sarmadi, J., McCarthy, S., Betteridge, D. J., & Wolff, S. P. (1995) · Diabetes · doi:10.2337/diab.44.9.1054 · Cited by 282
Vascular Superoxide Production and Vasomotor Function in Hypertension Induced by Deoxycorticosterone Acetate–Salt
Somers, M. J., Mavromatis, K., Galis, Z. S., & Harrison, D. G. (2000) · Circulation · doi:10.1161/01.cir.101.14.1722 · Cited by 280
Increased Formation of Distinct F2Isoprostanes in Hypercholesterolemia
Reilly, M. P., Praticò, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D. J., Kapoor, S. C., Rokach, J., Lawson, J. A., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.25.2822 · Cited by 271
Reactive Oxygen Species and Protein Oxidation in Aging: A Look Back, A Look Ahead
Hensley, K., & Floyd, R. A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2630 · Cited by 255
Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase.
Krieger‐Brauer, H. I., & KATHER, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115641 · Cited by 233
Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes
Rudich, A., Kozlovsky, N., Potashnik, R., & Bashan, N. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.5.e935 · Cited by 188
Insulin Signaling Is Inhibited by Micromolar Concentrations of H2O2
Hansen, L. L., Ikeda, Y., Olsen, G. S., Busch, A. K., & Mosthaf, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25078 · Cited by 181
Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry
Proudfoot, J. M., Barden, A. E., Mori, T. A., Burke, V., Croft, K. D., Beilin, L. J., & Puddey, I. B. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4187 · Cited by 175
Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F 2 -isoprostanes in human urine
Li, H., Lawson, J. A., Reilly, M. P., Adiyaman, M., Hwang, S., Rokach, J., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13381 · Cited by 161
Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?
Facchini, F. S., Hua, N. W., Reaven, G. M., & Stoohs, R. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00438-x · Cited by 136
Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers.
Dietrich, M., Block, G., Hudes, M. L., Morrow, J. D., Norkus, E. P., Traber, M. G., Cross, C. E., & Packer, L. (2002) · PubMed · Cited by 132
The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression
Stary, H. C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01713-1 · Cited by 119
Subpressor Doses of Angiotensin II Increase Plasma F 2 -Isoprostanes in Rats
Reckelhoff, J. F., Zhang, H., Srivastava, K., Roberts, L. J., Morrow, J. D., & Romero, J. C. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.476 · Cited by 88
Quitting Cigarette Smoking Results in a Fast Improvement of in vivo Oxidation Injury (Determined via Plasma, Serum and Urinary Isoprostane)
Pilz, H., Oguogho, A., Chehne, F., Lupattelli, G., Palumbo, B., & Sinzinger, H. F. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00249-8 · Cited by 87
Impaired glucose tolerance as a disease
Baron, A. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01832-x · Cited by 54
Increase of isoprostane 8-epi-PGF2 αafter restarting smoking
Chehne, F., Oguogho, A., Lupattelli, G., Budinsky, A. C., Palumbo, B., & Sinzinger, H. F. (2001) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0277 · Cited by 45
LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2α
Oguogho, A., Ferlitsch, A., & Sinzinger, H. F. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0145 · Cited by 13
Formation of Isoprostanes in Children with Type IIa Hypercholesterolemia
Cracowski, J., Ploin, D., Bessard, J., Baguet, J.-P., Stanke‐Labesque, F., Mallion, J.-M., Bost, M., & Bessard, G. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200108000-00008 · Cited by 12

Research works printed but not linked: 10

10.1161/res.86.5.494 · DOI
10.1161/circ.95.3.588 · DOI
1995, Dtsch Med Wochenschr, 120, 1107.
10.1161/circ.99.2.224 · DOI
2002, Cancer Epidemiol Biomarkers Prev, 11, 7
1997, Am J Physiol, 272, E935
10.1161/circ.98.25.2822 · DOI
10.1161/hyp.35.1.476 · DOI
10.1161/circ.101.14.1722 · DOI
10.1161/atvb.22.3.438 · DOI

Sorted by citations

Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
Self-citation
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444

See all 1,304

Authors: Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J.
Affiliations: Boston University (US)
ORCID: Keaney, John F.
Larson, Martin G.
Vasan, Ramachandran S.
Wilson, Peter W.F.
Massaro, Joseph M.
Vita, Joseph A.
Benjamin, Emelia J.
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2003-03
Volume: 23
Issue: 3
Pages: 434-439
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.0000058402.34138.11
OpenAlex: W2131398405
Cited by: 1,304
References: 39
Citations by year: 2026: 10 · 2025: 20 · 2024: 27 · 2023: 30 · 2022: 44 · 2021: 52 · 2020: 44 · 2019: 45 · 2018: 51 · 2017: 67 · 2016: 71 · 2015: 82 · 2014: 74 · 2013: 97 · 2012: 93
FWCI: 32.81
Type: journal article
Language: en
Update notices: correction (2018-03-15)
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: American Heart Association (N01-HC-25195)
National Institutes of Health (5r01dk055656-03, n01hc025195-11-0-0, n01hv28178-12-0-0, N01-HC 25195, DK55656)
National Heart, Lung, and Blood Institute (P01HL060886, N01 HV28178, N01‐HC25195, K24HL004334, HL71039, R01HL064753, HL64753, HL-60886, R01HL071039, HL04334)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-55656)
Topics: Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: systemic oxidative stress, obesity, 8-isoprostane, urinary biomarkers, body mass index, diabetes mellitus, smoking, hypertension, cardiovascular risk factors, cardiovascular disease, Framingham Heart Study
MeSH terms: Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Sex Factors, Smoking, Dinoprost, Comorbidity, Body Mass Index, Multivariate Analysis, Oxidative Stress, F2-Isoprostanes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks